PLUS1
79.58
-1.17 (-1.45%)
-1.17 (-1.45%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 18,461,835 |
|
|||||
| News | - | ||||||
| Day High | 81.52 | Low High |
|||||
| Day Low | 79.24 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -1.17 | -1.45% | 79.58 | 20:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 81.04 | 79.24 | 81.52 | 79.98 | 80.75 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 135,233 | 18,461,835 | $ 80.11 | $ 1,478,885,385 | - | 70.89 - 91.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:31 | 2 | $ 79.58 | USD |
Period:
Draw Mode:
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 201.01B | 2.53B | 2.52B | $ 48.00B | $ 11.64B | 2.77 | 28.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.48 | 3.40% | 12/14/21 | -969.58k | 0.10% |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 81.60 | 82.16 | 79.24 | 81.25 | 11,863,780 | -2.02 | -2.48% |
| 1 Month | 75.97 | 82.56 | 75.35 | 79.82 | 10,928,383 | 3.61 | 4.75% |
| 3 Months | 86.485 | 91.40 | 71.50 | 79.06 | 13,898,694 | -6.91 | -7.98% |
| 6 Months | 76.34 | 91.40 | 70.89 | 78.36 | 13,530,528 | 3.24 | 4.24% |
| 1 Year | 81.67 | 91.40 | 70.89 | 77.44 | 12,763,281 | -2.09 | -2.56% |
| 3 Years | 75.57 | 92.64 | 65.25 | 79.64 | 10,834,061 | 4.01 | 5.31% |
| 5 Years | 61.81 | 92.64 | 52.83 | 73.66 | 10,375,774 | 17.77 | 28.75% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States. |
